pharma
dog
News
when
Latest
Archive
by source
All Sources
Sources Page
Jobs
department
Clinical
Regulatory
Medical Affairs
Commercial
R&D / Discovery
Biostatistics / Data
Manufacturing / CMC
Market Access
therapeutic area
Oncology
Immunology
Neuroscience
Cardiovascular
Metabolic
Rare Disease
Infectious Disease
location & type
Remote Only
US Only
California
Massachusetts
Internships
Phase 3 Roles
All Jobs →
◐
Sign In
Subscribe
🐶
home
jobs
news
search
Vaccine · news · pharmadog
← back to Vaccine
News · Vaccine
317
stories
15d
STAT+: FDA approves Replimune melanoma drug previously rejected twice
stat
15d
Erica Schwartz confirmed as next CDC director
biopharma dive
15d
STAT+: Study reveals new role for tau, a top target for Alzheimer’s drug development
stat
15d
STAT+: Two FDA approvals — a new drug and a new vaccine
stat
15d
U.S. moves to shut a Kentucky organ donation group, citing safety failures
stat
15d
Opinion: The U.S. needs a 9/11 Commission-style independent body to investigate Covid response
stat
15d
Senate committee votes along party lines to hold Fauci in contempt of Congress
stat
15d
STAT+: Pharmalittle: We’re reading about Moderna’s flu shot, a death in a gene-editing trial in China, and more
stat
15d
Opinion: One year since Kennedy canceled mRNA vaccine projects, science shows how wrong he was
stat
15d
Covid can reactivate dormant viruses, according to study
stat
15d
Moderna’s flu shot crosses FDA finish line, bouncing back from regulatory roadblock
biospace
15d
FDA approves Moderna’s mRNA flu vaccine
biopharma dive
15d
Opinion: What my colleagues and I will look for as we assess U.S. measles elimination status
stat
15d
FDA approves Moderna flu vaccine after spat with past agency leaders
endpoints
15d
FDA approves Moderna’s mRNA flu vaccine, the first to use the technology
stat
15d
Recon: FDA approves first drug for type 1 narcolepsy, mRNA flu vaccine; No merger talks between AstraZeneca-BMS
raps
16d
STAT+: Takeda’s narcolepsy drug approved by the FDA, seen as a boon for new class of treatments
stat
16d
Erica Schwartz confirmed as CDC director, filling nearly yearlong vacancy
stat
16d
STAT+: Could poop pills be the next treatment for food allergies?
stat
16d
STAT+: Once again, child dies in gene-editing trial in China, rekindling debate on transparency and safety
stat
16d
Earnings roundup: Gilead’s ‘uncertain’ future, Pfizer’s crossroads and Merck’s PCSK9 launch
biopharma dive
16d
STAT+: Moderna launches early trial of Ebola mRNA vaccine
stat
16d
STAT+: Pharmalittle: We’re reading about a Medicare pilot and orphan drugs, Pfizer cutbacks, and more
stat
16d
The main therapy used for children with autism faces changes under Medicaid
stat
17d
Ebola kills 1,700 in eastern Congo as the fastest-growing outbreak surges
stat
17d
Pfizer CEO defends $7B bolt-on M&A strategy as peers rush to buy
biospace
17d
Pfizer expands multibillion-dollar cost-cutting plan
biopharma dive
17d
BioNTech cuts sales forecast on slumping demand for COVID-19 vaccine
biospace
17d
Trans federal employees sue over revoked health coverage
stat
18d
RFK Jr. interview sparks corrections on vaccines, pandemics and measles
endpoints
← prev
page 4 of 11
next →
